HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.

AbstractOBJECTIVE:
Electrical vagus nerve stimulation inhibits proinflammatory cytokine production and prevents shock during lethal systemic inflammation through an alpha7 nicotinic acetylcholine receptor (alpha7nAChR)-dependent pathway to the spleen, termed the cholinergic anti-inflammatory pathway. Pharmacologic alpha7nAChR agonists inhibit production of the critical proinflammatory mediator high mobility group box 1 (HMGB1) and rescue mice from lethal polymicrobial sepsis. Here we developed a method of transcutaneous mechanical vagus nerve stimulation and then investigated whether this therapy can protect mice against sepsis lethality.
DESIGN:
Prospective, randomized study.
SETTING:
Institute-based research laboratory.
SUBJECTS:
Male BALB/c mice.
INTERVENTIONS:
Mice received lipopolysaccharide to induce lethal endotoxemia or underwent cecal ligation and puncture to induce polymicrobial sepsis. Mice were then randomized to receive electrical, transcutaneous, or sham vagus nerve stimulation and were followed for survival or euthanized at predetermined time points for cytokine analysis.
MEASUREMENTS AND MAIN RESULTS:
Transcutaneous vagus nerve stimulation dose-dependently reduced systemic tumor necrosis factor levels during lethal endotoxemia. Treatment with transcutaneous vagus nerve stimulation inhibited HMGB1 levels and improved survival in mice with polymicrobial sepsis, even when administered 24 hrs after the onset of disease.
CONCLUSIONS:
Transcutaneous vagus nerve stimulation is an efficacious treatment for mice with lethal endotoxemia or polymicrobial sepsis.
AuthorsJared M Huston, Margot Gallowitsch-Puerta, Mahendar Ochani, Kanta Ochani, Renqi Yuan, Mauricio Rosas-Ballina, Mala Ashok, Richard S Goldstein, Sangeeta Chavan, Valentin A Pavlov, Christine N Metz, Huan Yang, Christopher J Czura, Haichao Wang, Kevin J Tracey
JournalCritical care medicine (Crit Care Med) Vol. 35 Issue 12 Pg. 2762-8 (Dec 2007) ISSN: 0090-3493 [Print] United States
PMID17901837 (Publication Type: Evaluation Study, Journal Article, Research Support, N.I.H., Extramural, Comment)
Chemical References
  • Cytokines
  • HMGB1 Protein
Topics
  • Animals
  • Cytokines (blood)
  • Endotoxemia
  • HMGB1 Protein (blood)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neuroimmunomodulation
  • Prospective Studies
  • Random Allocation
  • Sepsis (immunology, therapy)
  • Survival Analysis
  • Transcutaneous Electric Nerve Stimulation (methods)
  • Vagus Nerve

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: